Endogenous IL-22 plays a dual role in arthritis: Regulation of established arthritis via IFN-γ responses

PLoS ONE

Volumn 9, Issue 3, 2014, Pages

  Justa, Shivali ^a   Zhou, Xiaoqun ^a   Sarkar, Sujata ^a  

^a UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN G1 ANTIBODY; IMMUNOGLOBULIN G2A ANTIBODY; IMMUNOGLOBULIN G2B ANTIBODY; INTERLEUKIN 10; INTERLEUKIN 17; INTERLEUKIN 22; INTERLEUKIN 22 RECEPTOR TYPE 1; INTERLEUKIN RECEPTOR; UNCLASSIFIED DRUG; COLLAGEN; FREUND ADJUVANT; INTERLEUKIN DERIVATIVE; INTERLEUKIN-22; INTERLEUKIN-22 RECEPTOR; NEUTRALIZING ANTIBODY;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY RESPONSE; ANTIGEN PRESENTING CELL; ARTHRITIS; ARTICLE; CD4+ T LYMPHOCYTE; CONTROLLED STUDY; CYTOKINE RESPONSE; DISEASE SEVERITY; FEMALE; LYMPHOID ORGAN; MALE; MOUSE; NONHUMAN; TH1 CELL; UPREGULATION; ANIMAL; ANTAGONISTS AND INHIBITORS; CHEMICALLY INDUCED; DBA MOUSE; DEFICIENCY; EXPERIMENTAL ARTHRITIS; GENE EXPRESSION REGULATION; GENETICS; IMMUNOLOGY; KNOCKOUT MOUSE; PATHOLOGY; SEVERITY OF ILLNESS INDEX; SIGNAL TRANSDUCTION;

ANIMALS; ANTIBODIES, NEUTRALIZING; ARTHRITIS, EXPERIMENTAL; COLLAGEN; FEMALE; FREUND'S ADJUVANT; GENE EXPRESSION REGULATION; INTERFERON-GAMMA; INTERLEUKIN-17; INTERLEUKINS; MALE; MICE; MICE, INBRED DBA; MICE, KNOCKOUT; RECEPTORS, INTERLEUKIN; SEVERITY OF ILLNESS INDEX; SIGNAL TRANSDUCTION; TH1 CELLS;

EID: 84899835126     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0093279     Document Type: Article

References (53)

1. Zenewicz LA, Flavell RA (2011) Recent advances in IL-22 biology. Int Immunol 23: 159-163.
2. Kotenko SV, Izotova LS, Mirochnitchenko OV, Esterova E, Dickensheets H, et al. (2001) Identification of the functional interleukin-22 (IL-22) receptor complex: the IL-10R2 chain (IL-10Rbeta) is a common chain of both the IL-10 and IL-22 (IL-10-related T cell-derived inducible factor, IL-TIF) receptor complexes. J Biol Chem 276: 2725-2732.
3. Zenewicz LA, Yancopoulos GD, Valenzuela DM, Murphy AJ, Stevens S, et al. (2008) Innate and adaptive interleukin-22 protects mice from inflammatory bowel disease. Immunity 29: 947-957.
4. Sonnenberg GF, Nair MG, Kirn TJ, Zaph C, Fouser LA, et al. (2010) Pathological versus protective functions of IL-22 in airway inflammation are regulated by IL-17A. J Exp Med 207: 1293-1305.
5. Zheng Y, Valdez PA, Danilenko DM, Hu Y, Sa SM, et al. (2008) Interleukin-22 mediates early host defense against attaching and effacing bacterial pathogens. Nat Med 14: 282-289. (Pubitemid 351347912)
6. Liang SC, Tan XY, Luxenberg DP, Karim R, Dunussi-Joannopoulos K, et al. (2006) Interleukin (IL)-22 and IL-17 are coexpressed by Th17 cells and cooperatively enhance expression of antimicrobial peptides. J Exp Med 203: 2271-2279. (Pubitemid 44498362)
7. Radaeva S, Sun R, Pan HN, Hong F, Gao B (2004) Interleukin 22 (IL-22) plays a protective role in T cell-mediated murine hepatitis: IL-22 is a survival factor for hepatocytes via STAT3 activation. Hepatology 39: 1332-1342. (Pubitemid 38569055)
8. Aujla SJ, Chan YR, Zheng M, Fei M, Askew DJ, et al. (2008) IL-22 mediates mucosal host defense against Gram-negative bacterial pneumonia. Nat Med 14: 275-281. (Pubitemid 351347908)
9. Ma HL, Liang S, Li J, Napierata L, Brown T, et al. (2008) IL-22 is required for Th17 cell-mediated pathology in a mouse model of psoriasis-like skin inflammation. J Clin Invest 118: 597-607. (Pubitemid 351206549)
10. Nakagome K, Imamura M, Kawahata K, Harada H, Okunishi K, et al. (2011) High expression of IL-22 suppresses antigen-induced immune responses and eosinophilic airway inflammation via an IL-10-associated mechanism. J Immunol 187: 5077-5089.
11. Sugimoto K, Ogawa A, Mizoguchi E, Shimomura Y, Andoh A, et al. (2008) IL-22 ameliorates intestinal inflammation in a mouse model of ulcerative colitis. J Clin Invest 118: 534-544. (Pubitemid 351206544)
12. Chang H, Hanawa H, Liu H, Yoshida T, Hayashi M, et al. (2006) Hydrodynamic-based delivery of an interleukin-22-Ig fusion gene ameliorates experimental autoimmune myocarditis in rats. J Immunol 177: 3635-3643. (Pubitemid 44359895)
13. Ikeuchi H, Kuroiwa T, Hiramatsu N, Kaneko Y, Hiromura K, et al. (2005) Expression of interleukin-22 in rheumatoid arthritis: potential role as a proinflammatory cytokine. Arthritis Rheum 52: 1037-1046. (Pubitemid 40530109)
14. Mitra A, Raychaudhuri SK, Raychaudhuri SP (2012) Functional role of IL-22 in psoriatic arthritis. Arthritis Res Ther 14: R65.
15. Kim KW, Kim HR, Park JY, Park JS, Oh HJ, et al. (2012) Interleukin-22 promotes osteoclastogenesis in rheumatoid arthritis through induction of RANKL in human synovial fibroblasts. Arthritis Rheum 64: 1015-1023.
16. da Rocha LF Jr, Duarte AL, Dantas AT, Mariz HA, Pitta Ida R, et al. (2012) Increased serum interleukin 22 in patients with rheumatoid arthritis and correlation with disease activity. J Rheumatol 39: 1320-1325.
17. Zhang L, Li JM, Liu XG, Ma DX, Hu NW, et al. (2011) Elevated Th22 cells correlated with Th17 cells in patients with rheumatoid arthritis. J Clin Immunol 31: 606-614.
18. Leipe J, Schramm MA, Grunke M, Baeuerle M, Dechant C, et al. (2011) Interleukin 22 serum levels are associated with radiographic progression in rheumatoid arthritis. Ann Rheum Dis 70: 1453-1457.
19. Geboes L, Dumoutier L, Kelchtermans H, Schurgers E, Mitera T, et al. (2009) Proinflammatory role of the Th17 cytokine interleukin-22 in collagen-induced arthritis in C57BL/6 mice. Arthritis Rheum 60: 390-395.
20. Sarkar S, Zhou X, Justa S, Bommireddy SR (2013) Interleukin-22 reduces the severity of collagen-induced arthritis in association with increased levels of interleukin-10. Arthritis Rheum 65: 960-971.
21. Sarkar S, Cooney LA, White P, Dunlop DB, Endres J, et al. (2009) Regulation of pathogenic IL-17 responses in collagen-induced arthritis: roles of endogenous interferon-gamma and IL-4. Arthritis Res Ther 11: R158.
22. Sarkar S, Fox DA (2010) Targeting IL-17 and Th17 cells in rheumatoid arthritis. Rheum Dis Clin North Am 36: 345-366.
23. Schurgers E, Billiau A, Matthys P (2011) Collagen-induced arthritis as an animal model for rheumatoid arthritis: focus on interferon-gamma. J Interferon Cytokine Res 31: 917-926.
24. Kagami S, Rizzo HL, Lee JJ, Koguchi Y, Blauvelt A (2010) Circulating Th17, Th22, and Th1 cells are increased in psoriasis. J Invest Dermatol 130: 1373-1383.
25. Sugita S, Kawazoe Y, Imai A, Kawaguchi T, Horie S, et al. (2013) Role of IL-22- and TNF-alpha-producing Th22 cells in uveitis patients with Behcet's disease. J Immunol 190: 5799-5808.
26. Nograles KE, Zaba LC, Shemer A, Fuentes-Duculan J, Cardinale I, et al. (2009) IL-22-producing "T22" T cells account for upregulated IL-22 in atopic dermatitis despite reduced IL-17-producing TH17 T cells. J Allergy Clin Immunol 123: 1244-1252 e1242.
27. Zhang L, Li YG, Li YH, Qi L, Liu XG, et al. (2012) Increased frequencies of Th22 cells as well as Th17 cells in the peripheral blood of patients with ankylosing spondylitis and rheumatoid arthritis. PLoS One 7: e31000.
28. van Hamburg JP, Corneth OB, Paulissen SM, Davelaar N, Asmawidjaja PS, et al. (2013) IL-17/Th17 mediated synovial inflammation is IL-22 independent. Ann Rheum Dis.
29. Marijnissen RJ, Koenders MI, Smeets RL, Stappers MH, Nickerson-Nutter C, et al. (2011) Increased expression of interleukin-22 by synovial Th17 cells during late stages of murine experimental arthritis is controlled by interleukin-1 and enhances bone degradation. Arthritis Rheum 63: 2939-2948.
30. Ke Y, Sun D, Jiang G, Kaplan HJ, Shao H (2011) IL-22-induced regulatory CD11b+ APCs suppress experimental autoimmune uveitis. J Immunol 187: 2130-2139.
31. Chu CQ, Swart D, Alcorn D, Tocker J, Elkon KB (2007) Interferon-gamma regulates susceptibility to collagen-induced arthritis through suppression of interleukin-17. Arthritis Rheum 56: 1145-1151. (Pubitemid 46608639)
32. Irmler IM, Gajda M, Brauer R (2007) Exacerbation of antigen-induced arthritis in IFN-gamma-deficient mice as a result of unrestricted IL-17 response. J Immunol 179: 6228-6236.
33. Williams AS, Richards PJ, Thomas E, Carty S, Nowell MA, et al. (2007) Interferon-gamma protects against the development of structural damage in experimental arthritis by regulating polymorphonuclear neutrophil influx into diseased joints. Arthritis Rheum 56: 2244-2254. (Pubitemid 47173573)
34. Guedez YB, Whittington KB, Clayton JL, Joosten LA, van de Loo FA, et al. (2001) Genetic ablation of interferon-gamma up-regulates interleukin-1beta expression and enables the elicitation of collagen-induced arthritis in a nonsusceptible mouse strain. Arthritis Rheum 44: 2413-2424. (Pubitemid 32977511)
35. Chu CQ, Song Z, Mayton L, Wu B, Wooley PH (2003) IFNgamma deficient C57BL/6 (H-2b) mice develop collagen induced arthritis with predominant usage of T cell receptor Vbeta6 and Vbeta8 in arthritic joints. Ann Rheum Dis 62: 983-990. (Pubitemid 37159498)
36. Nakajima H, Takamori H, Hiyama Y, Tsukada W (1990) The effect of treatment with interferon-gamma on type II collagen-induced arthritis. Clin Exp Immunol 81: 441-445. (Pubitemid 20273670)
37. ManourySchwartz B, Chiocchia G, Bessis N, AbehsiraAmar O, Batteux F, et al. (1997) High susceptibility to collagen-induced arthritis in mice lacking IFN-gamma receptors. Journal of Immunology 158: 5501-5506.
38. Vermeire K, Heremans H, Vandeputte M, Huang S, Matthys P (1997) Accelerated collagen-induced arthritis in IFN-gamma receptor-deficient mice. Journal of Immunology 158: 5507-5513. (Pubitemid 127681260)
39. Nakahama T, Kimura A, Nguyen NT, Chinen I, Hanieh H, et al. (2011) Aryl hydrocarbon receptor deficiency in T cells suppresses the development of collagen-induced arthritis. Proc Natl Acad Sci U S A 108: 14222-14227.
40. Kelchtermans H, Struyf S, De Klerck B, Mitera T, Alen M, et al. (2007) Protective role of IFN-gamma in collagen-induced arthritis conferred by inhibition of mycobacteria-induced granulocyte chemotactic protein-2 production. J Leukoc Biol 81: 1044-1053. (Pubitemid 46495653)
41. Snapper CM, Paul WE (1987) Interferon-Gamma and B-Cell Stimulatory Factor-I Reciprocally Regulate Ig Isotype Production. Science 236: 944-947. (Pubitemid 17107942)
42. Snapper CM, Peschel C, Paul WE (1988) Ifn-Gamma Stimulates Igg2a Secretion by Murine B-Cells Stimulated with Bacterial Lipopolysaccharide. Journal of Immunology 140: 2121-2127. (Pubitemid 18098464)
43. Snapper CM, Rosas F, Moorman MA, Jin L, Shanebeck K, et al. (1996) IFN-gamma is a potent inducer of Ig secretion by sort-purified murine B cells activated through the mIg, but not the CD40, signaling pathway. International Immunology 8: 877-885.
44. Xu J, Foy TM, Laman JD, Elliott EA, Dunn JJ, et al. (1994) Mice deficient for the CD40 ligand. Immunity 1: 423-431.
45. Wolk K, Kunz S, Witte E, Friedrich M, Asadullah K, et al. (2004) IL-22 increases the innate immunity of tissues. Immunity 21: 241-254. (Pubitemid 39094053)
46. Lecart S, Morel F, Noraz N, Pene J, Garcia M, et al. (2002) IL-22, in contrast to IL-10, does not induce Ig production, due to absence of a functional IL-22 receptor on activated human B cells. Int Immunol 14: 1351-1356. (Pubitemid 35331432)
47. Boniface K, Bernard FX, Garcia M, Gurney AL, Lecron JC, et al. (2005) IL-22 inhibits epidermal differentiation and induces proinflammatory gene expression and migration of human keratinocytes. J Immunol 174: 3695-3702. (Pubitemid 40354080)
48. Xie MH, Aggarwal S, Ho WH, Foster J, Zhang Z, et al. (2000) Interleukin (IL)-22, a novel human cytokine that signals through the interferon receptor-related proteins CRF2-4 and IL-22R. J Biol Chem 275: 31335-31339.
49. Oral HB, Kotenko SV, Yilmaz M, Mani O, Zumkehr J, et al. (2006) Regulation of T cells and cytokines by the interleukin-10 (IL-10)-family cytokines IL-19, IL-20, IL-22, IL-24 and IL-26. Eur J Immunol 36: 380-388. (Pubitemid 43257461)
50. Wolk K, Witte E, Reineke U, Witte K, Friedrich M, et al. (2005) Is there an interaction between interleukin-10 and interleukin-22? Genes Immun 6: 8-18. (Pubitemid 40260128)
51. Bard JD, Gelebart P, Anand M, Amin HM, Lai R (2008) Aberrant expression of IL-22 receptor 1 and autocrine IL-22 stimulation contribute to tumorigenicity in ALK+ anaplastic large cell lymphoma. Leukemia 22: 1595-1603.
52. Savan R, McFarland AP, Reynolds DA, Feigenbaum L, Ramakrishnan K, et al. (2011) A novel role for IL-22R1 as a driver of inflammation. Blood 117: 575-584.
53. Gelebart P, Zak Z, Dien-Bard J, Anand M, Lai R (2011) Interleukin 22 signaling promotes cell growth in mantle cell lymphoma. Transl Oncol 4: 9-19.